Updated Jul 16, 2026
Regan Andrew has filed 1 SEC Form 4 filing across 1 company in the last 90 days.
Andrew Regan is the Chief Executive Officer and a Director of CDT Equity Inc., a clinical-stage biopharmaceutical company focused on developing pharmaceutical products for unmet medical needs. He holds a 10% ownership stake in the company.
| Role | Chief Executive Officer, Director |
|---|---|
| Notability | 20/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-05-14 | CDT | CDT Equity Inc. | A — Grant or award | 100.0K | $1.90 | $190K |
| 2026-05-14 | CDT | CDT Equity Inc. | A — Grant or award | 147.4K | — | |
| 2025-12-22 | CDT | CDT Equity Inc. | A — Grant or award | 224.8K | $1.79 | $402K |
| 2025-09-19 | CDT | CDT Equity Inc. | A — Grant or award | 1.12M | $0.69 | $769K |
Andrew Regan is the Chief Executive Officer and a Director of CDT Equity Inc., a clinical-stage biopharmaceutical company focused on developing pharmaceutical products for unmet medical needs. He holds a 10% ownership stake in the company.…
1 primary Form 4 filings in the last 90 days, covering 1 company.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Regan Andrew profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.